Caspase-4: A Therapeutic Target for Peptic Ulcer Disease
Author(s) -
Zbigniew Zasłona,
Ewelina Flis,
Ciara Nulty,
Jay Kearney,
Rebecca Fitzgerald,
Atiyekeogbebe Rita Douglas,
Deirdre McNamara,
Sinéad M. Smith,
Luke O'neill,
Emma M. Creagh
Publication year - 2020
Publication title -
immunohorizons
Language(s) - English
Resource type - Journals
ISSN - 2573-7732
DOI - 10.4049/immunohorizons.2000080
Subject(s) - pyroptosis , inflammasome , caspase 1 , secretion , helicobacter pylori , peptic , medicine , disease , downregulation and upregulation , peptic ulcer , immunology , cancer research , biology , inflammation , biochemistry , gene
Peptic ulcers are caused by the interaction between bacterial and host factors. This study demonstrates enhanced expression of caspase-4 in peptic ulcer patient biopsies, indicating that pyroptosis and noncanonical inflammasome activity may be processes involved in peptic ulcer disease. We show that primary murine macrophages infected with Helicobacter pylori upregulate caspase-11 (the ortholog of human caspase-4), activate caspase-1, and secrete IL-1β. We demonstrate that misoprostol (a stable PGE 1 analogue) decreased IL-1β secretion and delayed lethality in vivo in a murine peritonitis model. PGE 2 was shown to inhibit caspase-11-driven pyroptosis and IL-1β secretion in macrophages. Overall, we provide evidence for a pathological role of caspase-4/11 in peptic ulcer disease and propose that targeting caspase-4 or inhibiting pyroptosis may have therapeutic potential in the management of peptic ulcers.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom